Introduction: . Idiopathic pulmonary fibrosis (IPF) is a chronic disease of unknown origin characterized by progressive scarring of the lung leading to irreversible loss of function. Despite the availability of two drugs that are able to slow down disease progression, IPF remains a deadly disease. The pathogenesis of IPF is poorly understood, but a dysregulated wound healing response following recurrent alveolar epithelial injury is thought to be crucial. Areas covered. In the last few years, the role of the immune system in IPF pathobiology has been reconsidered; indeed, recent data suggest that a dysfunctional immune system may promote and unfavorable interplay with pro-fibrotic pathways thus acting as a cofactor in disease development and progression. In this article, we review and critically discuss the role of T cells in the pathogenesis and progression of IPF in the attempt to highlight ways in which further research in this area may enable the development of targeted immunomodulatory therapies for this dreadful disease. Expert opinion: A better understanding of T cells interactions has the potential to facilitate the development of immune modulators targeting multiple T cell-mediated pathways thus halting disease initiation and progression.

The role of immune response in the pathogenesis of idiopathic pulmonary fibrosis: far beyond the Th1/Th2 imbalance / Spagnolo, Paolo; Tonelli, Roberto; Samarelli, ANNA VALERIA; Castelli, Gioele; Cocconcelli, Elisabetta; Petrarulo, Simone; Cerri, Stefania; Bernardinello, Nicol; Clini, Enrico; Saetta, Marina; Balestro., Elisabetta. - In: EXPERT OPINION ON THERAPEUTIC TARGETS. - ISSN 1472-8222. - 26:7(2022), pp. 617-631. [10.1080/14728222.2022.2114897]

The role of immune response in the pathogenesis of idiopathic pulmonary fibrosis: far beyond the Th1/Th2 imbalance.

Roberto Tonelli;Anna Valeria Samarelli;Enrico Clini;
2022

Abstract

Introduction: . Idiopathic pulmonary fibrosis (IPF) is a chronic disease of unknown origin characterized by progressive scarring of the lung leading to irreversible loss of function. Despite the availability of two drugs that are able to slow down disease progression, IPF remains a deadly disease. The pathogenesis of IPF is poorly understood, but a dysregulated wound healing response following recurrent alveolar epithelial injury is thought to be crucial. Areas covered. In the last few years, the role of the immune system in IPF pathobiology has been reconsidered; indeed, recent data suggest that a dysfunctional immune system may promote and unfavorable interplay with pro-fibrotic pathways thus acting as a cofactor in disease development and progression. In this article, we review and critically discuss the role of T cells in the pathogenesis and progression of IPF in the attempt to highlight ways in which further research in this area may enable the development of targeted immunomodulatory therapies for this dreadful disease. Expert opinion: A better understanding of T cells interactions has the potential to facilitate the development of immune modulators targeting multiple T cell-mediated pathways thus halting disease initiation and progression.
19-ago-2022
26
7
617
631
The role of immune response in the pathogenesis of idiopathic pulmonary fibrosis: far beyond the Th1/Th2 imbalance / Spagnolo, Paolo; Tonelli, Roberto; Samarelli, ANNA VALERIA; Castelli, Gioele; Cocconcelli, Elisabetta; Petrarulo, Simone; Cerri, Stefania; Bernardinello, Nicol; Clini, Enrico; Saetta, Marina; Balestro., Elisabetta. - In: EXPERT OPINION ON THERAPEUTIC TARGETS. - ISSN 1472-8222. - 26:7(2022), pp. 617-631. [10.1080/14728222.2022.2114897]
Spagnolo, Paolo; Tonelli, Roberto; Samarelli, ANNA VALERIA; Castelli, Gioele; Cocconcelli, Elisabetta; Petrarulo, Simone; Cerri, Stefania; Bernardinello, Nicol; Clini, Enrico; Saetta, Marina; Balestro., Elisabetta
File in questo prodotto:
File Dimensione Formato  
Spagnolo (Immune response and pathogenesis of IPF- review 2022).pdf

embargo fino al 31/08/2023

Tipologia: Versione dell'editore (versione pubblicata)
Dimensione 3.39 MB
Formato Adobe PDF
3.39 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1285704
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact